补肾解毒方联合耳穴压豆对晚期结直肠癌患者癌性疼痛及生活质量的影响

石建娜, 周新东, 孙科, 石海波, 陈霞

石建娜, 周新东, 孙科, 石海波, 陈霞. 补肾解毒方联合耳穴压豆对晚期结直肠癌患者癌性疼痛及生活质量的影响[J]. 实用临床医药杂志, 2024, 28(7): 41-44. DOI: 10.7619/jcmp.20240185
引用本文: 石建娜, 周新东, 孙科, 石海波, 陈霞. 补肾解毒方联合耳穴压豆对晚期结直肠癌患者癌性疼痛及生活质量的影响[J]. 实用临床医药杂志, 2024, 28(7): 41-44. DOI: 10.7619/jcmp.20240185
SHI Jianna, ZHOU Xindong, SUN Ke, SHI Haibo, CHEN Xia. Effects of Bushen Jiedu Formula combined with auricular pressure by coxherb seeds on cancer-induced pain and quality of life in patients with advanced colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 41-44. DOI: 10.7619/jcmp.20240185
Citation: SHI Jianna, ZHOU Xindong, SUN Ke, SHI Haibo, CHEN Xia. Effects of Bushen Jiedu Formula combined with auricular pressure by coxherb seeds on cancer-induced pain and quality of life in patients with advanced colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 41-44. DOI: 10.7619/jcmp.20240185

补肾解毒方联合耳穴压豆对晚期结直肠癌患者癌性疼痛及生活质量的影响

基金项目: 

江苏省无锡市中医药管理局科技项目 ZYYB202216

详细信息
    通讯作者:

    周新东, E-mail: 515028330@qq.com

  • 中图分类号: R735.3;R441.1;R242

Effects of Bushen Jiedu Formula combined with auricular pressure by coxherb seeds on cancer-induced pain and quality of life in patients with advanced colorectal cancer

  • 摘要:
    目的 

    探讨补肾解毒方联合耳穴压豆对晚期结直肠癌患者癌性疼痛及生活质量的影响。

    方法 

    将2019年6月—2023年5月本院收治的120例晚期结直肠癌患者纳入本研究,并将其随机分为2组。对照组(60例)行常规护理和“三阶梯”镇痛法干预疼痛,观察组(60例)在对照组基础上行补肾解毒方联合耳穴压豆治疗, 2组均持续治疗1个月。比较2组患者治疗前后数字评分量表(NRS)评分、治疗效果、生活质量量表(QOL)评分、不良反应发生情况,检测血清中P物质(SP)、β内啡肽(β-EP)、前列腺素E2(PGE2)水平。

    结果 

    治疗后,观察组NRS评分以及SP、β-EP和PGE2水平分别为(2.23±0.64) 分、(11.51±2.64) ng/mL、(78.64±9.46) ng/L、(41.90±6.32) ng/L, 分别低于对照组的(2.87±1.25)分、(15.64±2.42) ng/mL、(101.29±11.26) ng/L、(78.63±10.17) ng/L, 差异有统计学意义(P < 0.05); 观察组治疗总有效率为90.00%, QOL评分为(51.92±5.66)分,分别高于对照组的75.00%、(43.58±5.12) 分,差异有统计学意义(P < 0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。

    结论 

    补肾解毒方联合耳穴压豆可明显改善晚期结直肠癌患者的癌性疼痛,提高生活质量,且安全性较好。

    Abstract:
    Objective 

    To explore the effects of Bushen Jiedu Formula combined with auricular pressure by coxherb seeds on cancer pain and quality of life in patients with advanced colorectal cancer.

    Methods 

    A total of 120 patients with advanced colorectal cancer admitted to our hospital from June 2019 to May 2023 were included in the study, and were randomly divided into two groups. The control group (60 cases) received routine nursing care and the "three-step" analgesic method to intervene pain, while the observation group (60 cases) received treatment with Bushen Jiedu Formula combined with auricular pressure by coxherb seeds on the basis of the control group. Both groups were treated for one month. The Numerical Rating Scale (NRS) score, the therapeutic effect, the quality of life (QOL) score and the occurrence of adverse reactions were compared between the two groups before and after treatment, and the levels of substance P (SP), β-endorphin (β-EP) and prostaglandin E2(PGE2) of the two groups before and after treatment in serum were detected.

    Results 

    After treatment, the NRS score and the levels of SP, β-EP and PGE2 in the observation group were (2.23±0.64), (11.51±2.64) ng/mL, (78.64±9.46) ng/L and (41.90±6.32) ng/L, respectively, which were lower than (2.87±1.25), (15.64±2.42) ng/mL, (101.29±11.26) ng/L and (78.63±10.17) ng/L, respectively of the control group (P < 0.05). The total effective rate and QOL score of the observation group were 90.00% and (51.92±5.66), which were higher than 75.00% and (43.58±5.12), respectively of the control group (P < 0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).

    Conclusion 

    The combination of Bushen Jiedu Formula and auricular pressure by coxherb seeds can obviously improve the cancer-induced pain of patients with advanced colorectal cancer, improve their quality of life, and have good safety.

  • 表  1   2组NRS评分比较(x ± s

    时点 对照组(n=60) 观察组(n=60)
    治疗前 5.53±1.34 5.37±1.12
    治疗后 2.87±1.25* 2.23±0.64*#
    与治疗前比较, *P < 0.05; 与对照组比较, #P < 0.05。
    下载: 导出CSV

    表  2   2组患者治疗效果比较[n(%)]

    组别 完全缓解 部分缓解 轻度缓解 无效 总有效
    对照组(n=60) 7(11.67) 23(38.33) 15(25.00) 15(25.00) 45(75.00)
    观察组(n=60) 11(18.33) 26(43.33) 17(28.33) 6(10.00) 54(90.00)*
    与对照组比较, *P < 0.05。
    下载: 导出CSV

    表  3   2组患者治疗前后生活质量量表评分比较(x ± s

    时点 对照组(n=60) 观察组(n=60)
    治疗前 23.60±3.74 24.23±3.68
    治疗后 43.58±5.12* 51.92±5.66*#
    与治疗前比较, *P < 0.05; 与对照组比较, #P < 0.05。
    下载: 导出CSV

    表  4   2组治疗前后血清SP、β-EP、PGE2水平比较(x ± s)

    指标 时点 对照组(n=60) 观察组(n=60)
    SP/(ng/mL) 治疗前 22.39±3.19 21.76±2.53
    治疗后 15.64±2.42* 11.51±2.64*#
    β-EP/(ng/L) 治疗前 137.45±14.53 136.44±14.56
    治疗后 101.29±11.26* 78.64±9.46*#
    PGE2/(ng/L) 治疗前 198.31±20.57 199.64±20.35
    治疗后 78.63±10.17* 41.90±6.32*#
    SP: 血清P物质; β-EP: β内啡肽; PGE2: 前列腺素E2。与治疗前比较, *P < 0.05; 与对照组比较, #P < 0.05。
    下载: 导出CSV

    表  5   2组不良反应发生情况比较[n(%)]

    组别 恶心呕吐 头晕 腹痛腹泻 便秘
    对照组(n=60) 12(20.00) 19(31.67) 10(16.67) 4(6.67)
    联合组(n=60) 14(23.33) 16(26.67) 7(11.67) 6(10.00)
    下载: 导出CSV
  • [1]

    VIRGEN C G, KELKAR N, TRAN A, et al. Pharmacological management of cancer pain: novel therapeutics[J]. Biomedecine Pharmacother, 2022, 156: 113871. doi: 10.1016/j.biopha.2022.113871

    [2]

    COVELER A L, MIZRAHI J, EASTMAN B, et al. Pancreas cancer-associated pain management[J]. Oncologist, 2021, 26(6): e971-e982. doi: 10.1002/onco.13796

    [3] 刘宁宁, 杨越, 贾茹, 等. 补肾解毒方联合姑息化疗对晚期结直肠癌患者癌因性疲乏的影响[J]. 上海中医药杂志, 2021, 55(7): 59-63. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ202107015.htm
    [4] 程君, 刘慧, 王璐. 正念癌症康复训练结合耳穴压豆护理对肠癌化疗患者的影响[J]. 中国肿瘤临床与康复, 2022, 29(2): 253-256. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZK202202031.htm
    [5] 国家卫生计生委医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2015版)[J]. 中华胃肠外科杂志, 2015(10): 961-973. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHPD201506023.htm
    [6] 中国抗癌协会癌症康复与姑息治疗专业委员会(CRPC)难治性癌痛学组. 难治性癌痛专家共识(2017年版)[J]. 中国肿瘤临床, 2017, 44(16): 787-793. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL201909015.htm
    [7] 陈美玲, 吁佳, 杨菊莲, 等. 艾灸联合耳穴压豆及穴位贴敷对肺癌化疗患者癌因性疲乏及生活质量的影响[J]. 云南中医中药杂志, 2021, 42(6): 87-89. doi: 10.3969/j.issn.1007-2349.2021.06.027
    [8] 杜莉, 许远, 张炼, 等. 自拟癌痛止痛贴膏联合盐酸羟考酮治疗难治性癌性疼痛的效果观察[J]. 中华全科医学, 2022, 20(7): 1094-1097, 1121. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202207004.htm
    [9] 谭冠先, 罗健, 屠伟峰. 癌痛治疗学[M]. 郑州: 河南科学技术出版社, 2019: 38-39.
    [10] 张莹, 张玲玲, 热依娜·吾甫里. 系统性疼痛护理管理对晚期癌症患者疼痛程度、心理情绪与生活质量的影响[J]. 河北医药, 2022, 44(1): 154-156. doi: 10.3969/j.issn.1002-7386.2022.01.036
    [11]

    YANG J, WAHNER-ROEDLER D L, ZHOU X, et al. Acupuncture for palliative cancer pain management: systematic review[J]. BMJ Support Palliat Care, 2021, 11(3): 264-270. doi: 10.1136/bmjspcare-2020-002638

    [12]

    BROZOVICG, LESAR N, JANEV D, et al. Cancer pain and therapy[J]. Acta Clin Croat, 2022, 61(Suppl 2): 103-108.

    [13] 王院春, 羊璞, 惠建荣, 等. 中医外治法治疗癌性疼痛的临床研究[J]. 世界中医药, 2021, 16(14): 2207-2210. doi: 10.3969/j.issn.1673-7202.2021.14.026
    [14] 陈润, 曾睿芳, 方平, 等. 耳穴压豆联合盐酸羟考酮缓释片对癌性疼痛患者疼痛爆发次数及PPI与KPS评分的影响[J]. 西部医学, 2021, 33(11): 1683-1686. doi: 10.3969/j.issn.1672-3511.2021.11.025
    [15]

    GUTIERREZ S, EISENACH J C, BOADA M D. Seeding of breast cancer cell line (MDA-MB-231LUC+) to the mandible induces overexpression of substance P and CGRP throughout the trigeminal ganglion and widespread peripheral sensory neuropathy throughout all three of its divisions[J]. Mol Pain, 2021, 17: 17448069211024082.

    [16]

    ROBINSON P, RODRIGUEZ E, MUÑOZ M. Substance P-friend or foe[J]. J Clin Med, 2022, 11(13): 3609. doi: 10.3390/jcm11133609

    [17]

    ZHAO G H, SHI Y Q, GONG C Y, et al. Curcumin exerts antinociceptive effects in cancer-induced bone pain via an endogenous opioid mechanism[J]. Front Neurosci, 2021, 15: 696861. doi: 10.3389/fnins.2021.696861

    [18] 贺杰, 孙睿, 王振红, 等. 超声引导下腹横肌平面阻滞与腰方肌阻滞在直肠癌患者腹腔镜手术中的应用[J]. 实用临床医药杂志, 2022, 26(8): 95-98, 103. doi: 10.7619/jcmp.20214629
表(5)
计量
  • 文章访问数:  119
  • HTML全文浏览量:  17
  • PDF下载量:  11
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-01-09
  • 修回日期:  2024-03-11
  • 网络出版日期:  2024-04-21
  • 刊出日期:  2024-04-14

目录

    /

    返回文章
    返回
    x 关闭 永久关闭